Niacin in pharmacological doses alters microRNA expression in skeletal muscle of obese Zucker rats

PLoS ONE

Volumn 9, Issue 5, 2014, Pages

  Couturier, Aline ^a   Keller, Janine ^a   Most, Erika ^a   Ringseis, Robert ^a   Eder, Klaus ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MITOGEN ACTIVATED PROTEIN KINASE; NICOTINIC ACID; MESSENGER RNA; NICOTINAMIDE; NICOTINIC ACID DERIVATIVE; NICOTINURIC ACID; VITAMIN B COMPLEX;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA BINDING; DOWN REGULATION; DRUG BLOOD LEVEL; DRUG MECHANISM; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE INTERACTION; MALE; MICROARRAY ANALYSIS; NONHUMAN; OBESITY; QUANTITATIVE ANALYSIS; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA DEGRADATION; SKELETAL MUSCLE; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION; UPREGULATION; VALIDATION PROCESS; WNT SIGNALING PATHWAY; ZUCKER RAT; ANIMAL; BIOLOGY; BLOOD; BODY WEIGHT; DNA MICROARRAY; GENE REGULATORY NETWORK; METABOLISM; PHENOTYPE; SIGNAL TRANSDUCTION;

ANIMALS; BODY WEIGHT; COMPUTATIONAL BIOLOGY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORKS; MALE; MICRORNAS; MUSCLE, SKELETAL; NIACIN; NIACINAMIDE; NICOTINIC ACIDS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHENOTYPE; RATS; RATS, ZUCKER; RNA, MESSENGER; SIGNAL TRANSDUCTION; VITAMIN B COMPLEX;

EID: 84901293971     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0098313     Document Type: Article

References (52)

1. Gille A, Bodor ET, Ahmed K, Offermanns S (2008) Nicotinic acid: pharmacological effects and mechanisms of action. Annu. Rev. Pharmacol. Toxicol. 48: 79-106. (Pubitemid 351738150)
2. Guyton JR (1998) Effect of niacin on atherosclerotic cardiovascular diseas. Am. J. Cardiol. 82: 18U-23U; discussion 39U-41U.
3. Ganji SH, Kamanna VS, Kashyap ML (2003) Niacin and cholesterol: role in cardiovascular disease (review). J. Nutr. Biochem. 14: 298-305. (Pubitemid 36836234)
4. Kamanna VS, Kashyap ML (2008) Mechanism of action of niacin. Am. J. Cardiol. 101: 20B-26B.
5. Carlson LA (2005) Nicotinic acid: the broad-spectrum lipid drug. A 50th anniversary review. J. Intern. Med. 25: 94-114.
6. Hernandez C, Molusky M, Li Y, Li S, Lin JD (2010) Regulation of hepatic ApoC3 expression by PGC-1b mediates hypolipidemic effect of nicotinic acid. Cell Metab. 12: 411-419.
7. Ringseis R, Rosenbaum S, Gessner DK, Herges L, Kubens JF, et al. (2013) Supplementing obese Zucker rats with niacin induces the transition of glycolytic to oxidative skeletal muscle fibers. J. Nutr. 143: 125-131.
8. Schuler M, Ali F, Chambon C, Duteil D, Bornert J, et al. (2006) PGC1alpha expression is controlled in skeletal muscles by PPARbeta, whose ablation results in fiber-type switching, obesity, and type 2 diabetes. Cell Metab. 4: 407-414. (Pubitemid 44645068)
9. Wang Y, Zhang C, Yu RT, Cho HK, Nelson MC, et al. (2004) Regulation of muscle fiber type and running endurance by PPARdelta. PLoS Biol. 2: e294.
10. Lin J, Wu H, Tarr PT, Zhang C, Wu Z, et al. (2002) Transcriptional co-activator PGC-1 alpha drives the formation of slow-twitch muscle fibres. Nature 418: 797-801.
11. Lin J, Handschin C, Spiegelman BM (2005) Metabolic control through the PGC-1 family of transcription coactivators. Cell Metab. 1: 361-370. (Pubitemid 43960626)
12. Krek A, Grün D, Poy MN, Wolf R, Rosenberg L, et al. (2005) Combinatorial microRNA target predictions. Nat. Genet. 37: 495-500. (Pubitemid 40617277)
13. Hutvágner G, Zamore PD (2002) A microRNA in a multiple-turnover RNAi enzyme complex. Science 297: 2056-2060.
14. Song J, Smith SK, Hannon GJ, Joshua-Tor L (2004) Crystal structure of Argonaute and its implications for RISC slicer activity. Science 305: 1434-1437. (Pubitemid 39167656)
15. Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
16. Lewis BP, Burge CB, Bartel DP (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120: 15-20. (Pubitemid 40094598)
17. Peng X, Vaishnav A, Murillo G, Alimirah F, Torres KEO, et al. (2010) Protection against cellular stress by 25-hydroxyvitamin D3 in breast epithelial cells. J. Cell. Biochem. 110: 1324-1333.
18. Wang WW, Chatterjee N, Chittur SV, Welsh J, Tenniswood MP (2011) Effects of 1a,25 dihydroxyvitamin D3 and testosterone on miRNA and mRNA expression in LNCaP cells. Mol. Cancer 10: 58.
19. Bao B, Rodriguez-Melendez R, Wijeratne SSK, Zempleni J (2010) Biotin regulates the expression of holocarboxylase synthetase in the miR-539 pathway in HEK-293 cells. J. Nutr. 140: 1546-1551.
20. Karere GM, Glenn JP, VandeBerg JL, Cox LA (2012) Differential microRNA response to a high-cholesterol, high-fat diet in livers of low and high LDL-C baboons. BMC Genomics 13: 320.
21. Parra P, Serra F, Palou A (2010) Expression of adipose microRNAs is sensitive to dietary conjugated linoleic acid treatment in mice. PLoS ONE 5: e13005.
22. Garzon R, Pichiorri F, Palumbo T, Visentini M, Aqeilan R, et al. (2007) MicroRNA gene expression during retinoic acid-induced differentiation of human acute promyelocytic leukemia. Oncogene 26: 4148-4157. (Pubitemid 46920170)
23. Terao M, Fratelli M, Kurosaki M, Zanetti A, Guarnaccia V, et al. (2011) Induction of miR-21 by retinoic acid in estrogen receptor-positive breast carcinoma cells: biological correlates and molecular targets. J. Biol. Chem. 286: 4027-4042.
24. National Research Council, editor (1985) Guide for the care and use of laboratory animals. Washington, DC: National Institute of Health.
25. Liu M, Zhang D, Wang X, Zhang L, Han J, et al. (2012) Simultaneous quantification of niacin and its three main metabolites in human plasma by LCMS/MS. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 904: 107-114.
26. Scholz K, Kynast AM, Couturier A, Mooren F, Krüger K, et al. (2013) Supplementing healthy rats with a high-niacin dose has no effect on muscle fiber distribution and muscle metabolic phenotype. Eur J Nutr. (Epub ahead of print; DOI: 10.1007/s00394-013-0624-5).
27. Ritchie ME, Silver J, Oshlack A, Holmes M, Diyagama D, et al. (2007) A comparison of background correction methods for two-colour microarrays. Bioinformatics 23: 2700-2707. (Pubitemid 350048334)
28. Edgar R, Domrachev M, Lash AE (2002) Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res. 30: 207-210. (Pubitemid 34679544)
29. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408. (Pubitemid 34164012)
30. Keller J, Ringseis R, Koc A, Lukas I, Kluge H, et al. (2012) Supplementation with l-carnitine downregulates genes of the ubiquitin proteasome system in the skeletal muscle and liver of piglets. Animal 6: 70-78.
31. Humphreys DT, Westman BJ, Martin DIK, Preiss T (2005) MicroRNAs control translation initiation by inhibiting eukaryotic initiation factor 4E/cap and poly(A) tail function. Proc. Natl. Acad. Sci. U.S.A. 102: 16961-16966. (Pubitemid 41692666)
32. Li D, Tian Y, Guo J, Sun W, Lun Y, et al. (2013) Nicotinamide supplementation induces detrimental metabolic and epigenetic changes in developing rats. Br. J. Nutr. 110: 2156-2164.
33. Kirkland JB (2009) Niacin status, NAD distribution and ADP-ribose metabolism. Curr. Pharm. Des. 15: 3-11.
34. Weijts BG, Bakker WJ, Cornelissen PW, Liang KH, Schaftenaar FH, et al. (2012) E2F7 and E2F8 promote angiogenesis through transcriptional activation of VEGFA in cooperation with HIF1. EMBO J. 31: 3871-3884.
35. Khan M, Couturier A, Kubens JF, Most E, Mooren FC, et al. (2013) Niacin supplementation induces type II to type I muscle fiber transition in skeletal muscle of sheep. Acta Vet. Scand. 55: 85.
36. Di Shao, Liu Y, Liu X, Zhu L, Cui Y, et al. (2010) PGC-1 beta-regulated mitochondrial biogenesis and function in myotubes is mediated by NRF-1 and ERRa. Mitochondrion 10: 516-527.
37. Pohl J, Ring A, Stremmel W (2002) Uptake of long-chain fatty acids in HepG2 cells involves caveolae: analysis of a novel pathway. J. Lipid Res. 43: 1390-1399.
38. Ring A, Le Lay S, Pohl J, Verkade P, Stremmel W (2006) Caveolin-1 is required for fatty acid translocase (FAT/CD36) localization and function at the plasma membrane of mouse embryonic fibroblasts. Biochim. Biophys. Acta 1761: 416-423. (Pubitemid 43776458)
39. Roepstorff C, Vistisen B, Roepstorff K, Kiens B (2004) Regulation of plasma long-chain fatty acid oxidation in relation to uptake in human skeletal muscle during exercise. Am. J. Physiol. Endocrinol. Metab. 287: E696-705. (Pubitemid 39237898)
40. Cisternas P, Henriquez JP, Brandan E, Inestrosa NC (2013) Wnt Signaling in Skeletal Muscle Dynamics: Myogenesis, Neuromuscular Synapse and Fibrosis. Mol. Neurobiol.
41. Watt MJ, Southgate RJ, Holmes AG, Febbraio MA (2004) Suppression of plasma free fatty acids upregulates peroxisome proliferator-activated receptor (PPAR) alpha and delta and PPAR coactivator 1alpha in human skeletal muscle, but not lipid regulatory genes. J. Mol. Endocrinol. 33: 533-544. (Pubitemid 39429575)
42. Knutti D, Kressler D, Kralli A (2001) Regulation of the transcriptional coactivator PGC-1 via MAPK-sensitive interaction with a repressor. Proc. Natl. Acad. Sci. U.S.A. 98: 9713-9718. (Pubitemid 32769369)
43. Wu BJ, Yan L, Charlton F, Witting P, Barter PJ, et al. (2010) Evidence that niacin inhibits acute vascular inflammation and improves endothelial dysfunction independent of changes in plasma lipids. Arterioscler. Thromb. Vasc. Biol. 30: 968-975.
44. Lipszyc PS, Cremaschi GA, Zubilete MZ, Bertolino MLA, Capani F, et al. (2013) Niacin Modulates Pro-inflammatory Cytokine Secretion. A Potential Mechanism Involved in its Anti-atherosclerotic Effect. Open Cardiovasc Med J 7: 90-98.
45. Wanders D, Graff EC, White BD, Judd RL (2013) Niacin increases adiponectin and decreases adipose tissue inflammation in high fat diet-fed mice. PLoS ONE 8: e71285.
46. Juffer P, Bakker AD, Klein-Nulend J, Jaspers RT (2014) Mechanical Loading by Fluid Shear Stress of Myotube Glycocalyx Stimulates Growth Factor Expression and Nitric Oxide Production. Cell Biochem. Biophys. [Epub ahead of print].
47. Benyó Z, Gille A, Kero J, Csiky M, Suchánková MC, et al. (2005) GPR109A (PUMA-G/HM74A) mediates nicotinic acid-induced flushing. J. Clin. Invest. 115: 3634-3640. (Pubitemid 43121852)
48. Quabbe HJ, Luyckx AS, L'age M, Schwarz C (1983) Growth hormone, cortisol, and glucagon concentrations during plasma free fatty acid depression: different effects of nicotinic acid and an adenosine derivative (BM 11.189). J. Clin. Endocrinol. Metab. 57: 410-414. (Pubitemid 13032499)
49. Westphal S, Borucki K, Taneva E, Makarova R, Luley C (2007) Extended-release niacin raises adiponectin and leptin. Atherosclerosis 193: 361-365. (Pubitemid 47058098)
50. Plaisance EP, Grandjean PW, Brunson BL, Judd RL (2008) Increased total and high-molecular weight adiponectin after extended-release niacin. Metab. Clin. Exp. 57: 404-409. (Pubitemid 351178732)
51. Hu Y, Zhang R, Zhang Y, Li J, Grossmann R, et al. (2012) In ovo leptin administration affects hepatic lipid metabolism and microRNA expression in newly hatched broiler chickens. J Anim Sci Biotechnol 3: 16.
52. Ge Q, Gérard J, Noël L, Scroyen I, Brichard SM (2012) MicroRNAs regulated by adiponectin as novel targets for controlling adipose tissue inflammation. Endocrinology 153: 5285-5296.